Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 10/2016

13.02.2016 | Head and Neck

Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey

verfasst von: Ulrike Schiller, Johanna Inhestern, Ulrike Burger, Susanne Singer, Orlando Guntinas-Lichius

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Predictors for smoking and alcohol drinking behavior were investigated in head and neck cancer survivors (HNCS) with survivorship of ≥6 months. 165 HNCS registered in a regional cancer registry and treated 2005–2014 were included. Patients completed a survey including the Fagerström Test for nicotine dependence and the Alcohol Use Disorders Identification Test. Smoking and drinking cessation rates were 51 and 13 %, respectively. Multinomial logistic regression analyses showed that male patients [odds ratio (OR) 35.4; confidence interval (CI) 7.5–168.1; p < 0.0001], single persons (OR 9.9; CI 2.5–40.0; p = 0.001), and younger patients (OR 1.1; CI 1.0–1.1; p = 0.002) had significantly higher probability to be current smokers. Male gender (OR 48.7; CI 5.0–470.7; p < 0.0001) and younger age (OR 1.1; CI 1.0–1.3; p = 0.003) were predictors of risky alcohol consumption. Male, young, and single smoking and/or drinking HNCS should be stimulated to take part in smoking and/or alcohol drinking cessation programs.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48(11):3282–3287PubMed Blot WJ, McLaughlin JK, Winn DM et al (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48(11):3282–3287PubMed
2.
Zurück zum Zitat Mashberg A, Boffetta P, Winkelman R, Garfinkel L (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72(4):1369–1375CrossRefPubMed Mashberg A, Boffetta P, Winkelman R, Garfinkel L (1993) Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 72(4):1369–1375CrossRefPubMed
3.
4.
Zurück zum Zitat Carter BD, Abnet CC, Feskanich D et al (2015) Smoking and mortality—beyond established causes. New Engl J Med 372(7):631–640CrossRefPubMed Carter BD, Abnet CC, Feskanich D et al (2015) Smoking and mortality—beyond established causes. New Engl J Med 372(7):631–640CrossRefPubMed
5.
Zurück zum Zitat Browman GP, Wong G, Hodson I et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. New Engl J Med 328(3):159–163CrossRefPubMed Browman GP, Wong G, Hodson I et al (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. New Engl J Med 328(3):159–163CrossRefPubMed
6.
Zurück zum Zitat Gillison ML, Zhang Q, Jordan R et al (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30(17):2102–2111CrossRefPubMedPubMedCentral Gillison ML, Zhang Q, Jordan R et al (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30(17):2102–2111CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat O’Shea R, Byrne H, Tuckett J, O’Leary G, Sheahan P (2015) Impact of current smoking and alcohol consumption on gastrostomy duration in patients with head and neck cancer undergoing definitive chemoradiotherapy. Otolaryngol Head Neck Surg 141(5):463–469CrossRef O’Shea R, Byrne H, Tuckett J, O’Leary G, Sheahan P (2015) Impact of current smoking and alcohol consumption on gastrostomy duration in patients with head and neck cancer undergoing definitive chemoradiotherapy. Otolaryngol Head Neck Surg 141(5):463–469CrossRef
8.
Zurück zum Zitat Lee DH, Roh JL, Baek S et al (2013) Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149(4):579–586CrossRefPubMed Lee DH, Roh JL, Baek S et al (2013) Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 149(4):579–586CrossRefPubMed
9.
Zurück zum Zitat Gan SJ, Dahlstrom KR, Peck BW et al (2013) Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593–2601CrossRefPubMedPubMedCentral Gan SJ, Dahlstrom KR, Peck BW et al (2013) Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer 119(14):2593–2601CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Deleyiannis FW, Thomas DB, Vaughan TL, Davis S (1996) Alcoholism: independent predictor of survival in patients with head and neck cancer. J Nat Cancer Inst 88(8):542–549CrossRefPubMed Deleyiannis FW, Thomas DB, Vaughan TL, Davis S (1996) Alcoholism: independent predictor of survival in patients with head and neck cancer. J Nat Cancer Inst 88(8):542–549CrossRefPubMed
11.
Zurück zum Zitat Lambert MT, Terrell JE, Copeland LA, Ronis DL, Duffy SA (2005) Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in two systems of care. Nicotine Tob Res 7(2):233–241CrossRefPubMed Lambert MT, Terrell JE, Copeland LA, Ronis DL, Duffy SA (2005) Cigarettes, alcohol, and depression: characterizing head and neck cancer survivors in two systems of care. Nicotine Tob Res 7(2):233–241CrossRefPubMed
12.
Zurück zum Zitat Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF (2010) Continued alcohol use in patients with head and neck cancer. Head Neck 32(7):905–912PubMed Potash AE, Karnell LH, Christensen AJ, Vander Weg MW, Funk GF (2010) Continued alcohol use in patients with head and neck cancer. Head Neck 32(7):905–912PubMed
13.
Zurück zum Zitat Sharp L, Johansson H, Fagerstrom K, Rutqvist LE (2008) Smoking cessation among patients with head and neck cancer: cancer as a ‘teachable moment’. Eur J Cancer Care 17(2):114–119CrossRef Sharp L, Johansson H, Fagerstrom K, Rutqvist LE (2008) Smoking cessation among patients with head and neck cancer: cancer as a ‘teachable moment’. Eur J Cancer Care 17(2):114–119CrossRef
14.
Zurück zum Zitat Duffy SA, Khan MJ, Ronis DL et al (2008) Health behaviors of head and neck cancer patients the first year after diagnosis. Head Neck 30(1):93–102CrossRefPubMed Duffy SA, Khan MJ, Ronis DL et al (2008) Health behaviors of head and neck cancer patients the first year after diagnosis. Head Neck 30(1):93–102CrossRefPubMed
15.
Zurück zum Zitat Simmons VN, Litvin EB, Jacobsen PB et al (2013) Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer 119(7):1420–1427CrossRefPubMed Simmons VN, Litvin EB, Jacobsen PB et al (2013) Predictors of smoking relapse in patients with thoracic cancer or head and neck cancer. Cancer 119(7):1420–1427CrossRefPubMed
16.
Zurück zum Zitat Narwani V, Harries M (2014) Treatment modality: a predictor of continued tobacco use after treatment in patients with laryngeal cancer. J Laryngol Otol 128(2):153–158CrossRefPubMed Narwani V, Harries M (2014) Treatment modality: a predictor of continued tobacco use after treatment in patients with laryngeal cancer. J Laryngol Otol 128(2):153–158CrossRefPubMed
17.
Zurück zum Zitat Genther DJ, Gourin CG (2012) The effect of alcohol abuse and alcohol withdrawal on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope 122(8):1739–1747CrossRefPubMed Genther DJ, Gourin CG (2012) The effect of alcohol abuse and alcohol withdrawal on short-term outcomes and cost of care after head and neck cancer surgery. Laryngoscope 122(8):1739–1747CrossRefPubMed
18.
Zurück zum Zitat D’Hoore W, Sicotte C, Tilquin C (1993) Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 32(5):382–387PubMed D’Hoore W, Sicotte C, Tilquin C (1993) Risk adjustment in outcome assessment: the Charlson comorbidity index. Methods Inf Med 32(5):382–387PubMed
19.
Zurück zum Zitat Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86(9):1119–1127CrossRefPubMed Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 86(9):1119–1127CrossRefPubMed
20.
Zurück zum Zitat Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH (1991) A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev 1(1):67–73 Gritz ER, Carr CR, Rapkin DA, Chang C, Beumer J, Ward PH (1991) A smoking cessation intervention for head and neck cancer patients: trial design, patient accrual, and characteristics. Cancer Epidemiol Biomark Prev 1(1):67–73
21.
Zurück zum Zitat Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88(6):791–804CrossRefPubMed Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88(6):791–804CrossRefPubMed
22.
Zurück zum Zitat Duffy SA, Ronis DL, Valenstein M et al (2007) Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 48(2):142–148CrossRefPubMed Duffy SA, Ronis DL, Valenstein M et al (2007) Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics 48(2):142–148CrossRefPubMed
23.
Zurück zum Zitat Giovino GA, Mirza SA, Samet JM et al (2012) Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 380(9842):668–679CrossRefPubMed Giovino GA, Mirza SA, Samet JM et al (2012) Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 380(9842):668–679CrossRefPubMed
24.
Zurück zum Zitat Shield KD, Rylett M, Gmel G, Gmel G, Kehoe-Chan TA, Rehm J (2013) Global alcohol exposure estimates by country, territory and region for 2005—a contribution to the comparative risk assessment for the 2010 global burden of disease study. Addiction 108(5):912–922CrossRefPubMed Shield KD, Rylett M, Gmel G, Gmel G, Kehoe-Chan TA, Rehm J (2013) Global alcohol exposure estimates by country, territory and region for 2005—a contribution to the comparative risk assessment for the 2010 global burden of disease study. Addiction 108(5):912–922CrossRefPubMed
25.
Zurück zum Zitat Bilano V, Gilmour S, Moffiet T et al (2015) Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet 385(9972):966–976CrossRefPubMed Bilano V, Gilmour S, Moffiet T et al (2015) Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet 385(9972):966–976CrossRefPubMed
26.
Zurück zum Zitat Hapke U, von der Lippe E, Gaertner B (2013) Alcohol consumption, at-risk and heavy episodic drinking with consideration of injuries and alcohol-specific medical advice: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundh Gesundh Gesundh 56(5–6):809–813CrossRef Hapke U, von der Lippe E, Gaertner B (2013) Alcohol consumption, at-risk and heavy episodic drinking with consideration of injuries and alcohol-specific medical advice: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundh Gesundh Gesundh 56(5–6):809–813CrossRef
27.
Zurück zum Zitat Lee YC, Zugna D, Richiardi L et al (2013) Smoking addiction and the risk of upper-aerodigestive-tract cancer in a multicenter case–control study. Int J Cancer 133(11):2688–2695PubMed Lee YC, Zugna D, Richiardi L et al (2013) Smoking addiction and the risk of upper-aerodigestive-tract cancer in a multicenter case–control study. Int J Cancer 133(11):2688–2695PubMed
28.
Zurück zum Zitat Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E (1999) Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21(5):420–427CrossRefPubMed Gritz ER, Schacherer C, Koehly L, Nielsen IR, Abemayor E (1999) Smoking withdrawal and relapse in head and neck cancer patients. Head Neck 21(5):420–427CrossRefPubMed
29.
Zurück zum Zitat Christensen AJ, Moran PJ, Ehlers SL, Raichle K, Karnell L, Funk G (1999) Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control. J Behav Med 22(5):407–418CrossRefPubMed Christensen AJ, Moran PJ, Ehlers SL, Raichle K, Karnell L, Funk G (1999) Smoking and drinking behavior in patients with head and neck cancer: effects of behavioral self-blame and perceived control. J Behav Med 22(5):407–418CrossRefPubMed
30.
Zurück zum Zitat Singer S, Keszte J, Thiele A et al (2010) Smoking behaviour after laryngectomy. Laryngo Rhino Otol 89(3):146–150CrossRef Singer S, Keszte J, Thiele A et al (2010) Smoking behaviour after laryngectomy. Laryngo Rhino Otol 89(3):146–150CrossRef
31.
32.
Zurück zum Zitat Ostroff JS, Jacobsen PB, Moadel AB et al (1995) Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 75(2):569–576CrossRefPubMed Ostroff JS, Jacobsen PB, Moadel AB et al (1995) Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer 75(2):569–576CrossRefPubMed
33.
Zurück zum Zitat Danker H, Keszte J, Singer S et al (2011) Alcohol consumption after laryngectomy. Clin Otolaryngol 36(4):336–344CrossRefPubMed Danker H, Keszte J, Singer S et al (2011) Alcohol consumption after laryngectomy. Clin Otolaryngol 36(4):336–344CrossRefPubMed
34.
Zurück zum Zitat Gritz ER, Carr CR, Rapkin D et al (1993) Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomark Prev 2(3):261–270 Gritz ER, Carr CR, Rapkin D et al (1993) Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomark Prev 2(3):261–270
35.
Zurück zum Zitat Duffy SA, Scheumann AL, Fowler KE, Darling-Fisher C, Terrell JE (2010) Perceived difficulty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer. Oncol Nurs Forum 37(3):349–356CrossRefPubMedPubMedCentral Duffy SA, Scheumann AL, Fowler KE, Darling-Fisher C, Terrell JE (2010) Perceived difficulty quitting predicts enrollment in a smoking-cessation program for patients with head and neck cancer. Oncol Nurs Forum 37(3):349–356CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Hatcher JL, Sterba KR, Tooze JA et al (2014) Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. doi: 10.1002/hed.23944. (Epub ahead of print) Hatcher JL, Sterba KR, Tooze JA et al (2014) Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. doi: 10.​1002/​hed.​23944. (Epub ahead of print)
37.
Zurück zum Zitat Kroke A, Klipstein-Grobusch K, Hoffmann K, Terbeck I, Boeing H, Helander A (2001) Comparison of self-reported alcohol intake with the urinary excretion of 5-hydroxytryptophol:5-hydroxyindole-3-acetic acid, a biomarker of recent alcohol intake. Br J Nutr 85(5):621–627CrossRefPubMed Kroke A, Klipstein-Grobusch K, Hoffmann K, Terbeck I, Boeing H, Helander A (2001) Comparison of self-reported alcohol intake with the urinary excretion of 5-hydroxytryptophol:5-hydroxyindole-3-acetic acid, a biomarker of recent alcohol intake. Br J Nutr 85(5):621–627CrossRefPubMed
Metadaten
Titel
Predictors of post-treatment smoking and drinking behavior of head and neck cancer survivors: results of a population-based survey
verfasst von
Ulrike Schiller
Johanna Inhestern
Ulrike Burger
Susanne Singer
Orlando Guntinas-Lichius
Publikationsdatum
13.02.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 10/2016
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-016-3924-6

Weitere Artikel der Ausgabe 10/2016

European Archives of Oto-Rhino-Laryngology 10/2016 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.